Estrella Immunopharma Files 8-K
Ticker: ESLAW · Form: 8-K · Filed: May 29, 2025 · CIK: 1844417
Sentiment: neutral
Topics: 8-K, corporate-filing, name-change
Related Tickers: ESLA
TL;DR
Estrella Immunopharma (formerly TradeUP Acquisition) filed an 8-K on 5/29/25. Nothing major disclosed yet.
AI Summary
Estrella Immunopharma, Inc. filed an 8-K on May 29, 2025, reporting other events and financial statements. The company, formerly known as TradeUP Acquisition Corp. until February 4, 2021, is based in Emeryville, California.
Why It Matters
This filing indicates ongoing corporate activity and reporting requirements for Estrella Immunopharma, Inc., formerly TradeUP Acquisition Corp.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for reporting purposes and does not disclose any new material events or financial distress.
Key Numbers
- 001-40608 — SEC File Number (Identifies the company's filing with the SEC.)
- 86-1314502 — IRS Employer Identification Number (Company's tax identification number.)
Key Players & Entities
- Estrella Immunopharma, Inc. (company) — Registrant
- TradeUP Acquisition Corp. (company) — Former company name
- May 29, 2025 (date) — Date of earliest event reported
- February 4, 2021 (date) — Date of name change
- Emeryville, California (location) — Company address
FAQ
What specific 'Other Events' are being reported in this 8-K filing?
The provided text does not detail the specific 'Other Events' beyond stating that this item is included in the filing.
What are the details of the financial statements and exhibits filed?
The filing indicates that 'Financial Statements and Exhibits' are included, but the specific content of these documents is not detailed in the provided text.
What was the reason for the name change from TradeUP Acquisition Corp. to Estrella Immunopharma, Inc.?
The filing states the date of the name change (February 4, 2021) but does not provide the reason for it.
What is Estrella Immunopharma, Inc.'s Standard Industrial Classification (SIC) code?
Estrella Immunopharma, Inc.'s SIC code is 2836, which corresponds to 'BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)'.
What is the exercise price for Estrella Immunopharma's warrants?
The filing mentions warrants exercisable for one share of common stock at an exercise price of $11.50.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 29, 2025 regarding Estrella Immunopharma, Inc. (ESLAW).